A Study to Determine the Safety and Efficacy of NT-501 With MHFM

Phase 3 Active not recruiting 12 enrolled Neurotech Pharmaceuticals

NaSingle-groupOpen-labelTreatment

Summary

This study is to determine the long-term levels of CNTF, and the clinical safety and efficacy of the NT-501 implants with the Medica Hollow Fiber Membrane (MHFM) in participants with macular telangiectasia type 2.

Timeline

Start: 2025-03-06
Primary completion: 2026-05-01
Completion: 2026-07-24

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ciliary neurotrophic factor	Cell therapy	—	Other

A Study to Determine the Safety and Efficacy of NT-501 With MHFM

Summary

Timeline

Drugs

Indications